Hair Transplant Cost: What Determines the Price of FUE

The short answer: price follows grafts, technique and who performs the work

Hair transplant cost in the United States reflects three principal factors: the number of grafts needed to address the area of thinning or loss, the harvesting method chosen, and who performs the extraction and placement. According to the International Society of Hair Restoration Surgery's 2025 Practice Census—a survey of member activity in 2024—the average follicular unit excision case involved 2,262 grafts, and FUE harvesting was used in 85.4 percent of male and 68.2 percent of female surgical procedures. Because every patient's degree of loss, hair characteristics and long-term pattern differ, the number of grafts required varies widely, and with it the surgical time, facility cost and physician effort.

The choice between shaved FUE, No-Shave FUE and strip harvesting also moves the price. No-Shave FUE—extracting individual follicular units without clipping the donor area—requires longer per-graft time and specialized skill, which increases the fee. Strip harvesting, in which a linear section of scalp is removed and dissected under magnification, accounted for 12.5 percent of male and 30.0 percent of female procedures in the census; it can offer a lower per-session cost but leaves a linear scar and may require suture removal.

Finally, who performs the work is both a quality and a cost variable. The ISHRS Consumer Advocacy page advises patients to ask who will evaluate their hair loss, who will perform each part of the surgery, what their licensure and training are, and whether anyone not licensed by the state will make incisions or harvest grafts. Dr. Charles Pereyra, MD—a board-certified emergency physician and member of the International Society of Hair Restoration Surgery—personally performs the Micrograft FUE procedure at Springs Rejuvenation, including both the extraction and placement phases, which are not delegated to a physician assistant or technician.

The factors that move a hair transplant cost

Published US market ranges — and why they are not a quote

The American Society of Plastic Surgeons blog stated in 2018 that hair restoration costs are based on the number of grafts and generally vary from six thousand dollars for small cases (typically one thousand grafts or fewer), ten thousand dollars for medium-sized cases (about fifteen hundred grafts) and twelve thousand to fifteen thousand dollars for large cases (two thousand or more grafts). The ISHRS emphasizes on its "Should the Cost of a Hair Transplant Matter?" page that prices vary regionally with cost of living and not necessarily the quality of care, and warns that some low-fee clinics bypass licensed physicians and skip safeguards.

These are published market ranges cited for context and are not Springs Rejuvenation pricing. Springs quotes one all-in price after the in-person Follicular Health Assessment, which allows Dr. Pereyra to evaluate the degree of miniaturization, donor density, hair caliber and long-term pattern specific to each patient.

Why per-graft pricing can work against the patient

Many clinics advertise a dollar-per-graft rate, which on its face appears transparent. In practice, however, per-graft pricing can create a perverse incentive: it rewards harvesting a higher number of grafts from a finite donor area, even when a conservative approach would preserve donor reserves for future sessions. The American Hair Loss Association's long-term planning page cautions that donor hair is finite and that planning should extend beyond the first procedure to account for the likelihood of progressive loss.

The AHLA Hair Transplant Surgery page further warns that the growing commercialization of hair restoration, aggressive marketing and high-volume clinics have introduced risks of irreversible donor hair depletion. When a surgeon is paid per graft, there is financial pressure to maximize the harvest—potentially at the expense of leaving enough density in the donor zone for a natural appearance if the patient returns years later with additional thinning. The 2025 ISHRS census reported an average FUE case size of 2,262 grafts, which provides useful context; a quote substantially above or below that figure warrants a conversation about whether the plan is tailored to the individual or optimized for throughput.

An all-in price based on a comprehensive assessment shifts the focus from graft count to outcome. The physician evaluates what the patient needs, proposes a number of grafts that the donor area can support sustainably, and quotes a single fee for the entire service—extraction, placement, facility time, follow-up—rather than selling grafts as a commodity.

The cost of getting it wrong

The ISHRS frames the "real cost" of a hair transplant as the repair work and donor damage that can follow a poorly planned or poorly executed procedure. The society's consumer advocacy materials note that all surgical incisions in hair transplantation form scars because any incision beyond the most superficial depth produces scar tissue, and that a January 31, 2020 position by the New York State Board for Professional Medical Conduct states that hair restoration surgery should only be performed by qualified physicians.

Repair cases—procedures intended to correct unnatural hairlines, visible linear scars, pluggy grafts or depleted donor zones—accounted for about 4 percent of male surgical cases in the 2025 census. While that percentage may seem small, each repair represents a patient who paid once for a procedure and is now paying again, often with fewer grafts available and more limited options. The ISHRS warns that some low-fee clinics bypass licensed physicians entirely, assigning incision-making and graft placement to unlicensed technicians, and that the savings at the front end can translate into far higher costs—financial and emotional—on the back end.

The questions the ISHRS advises patients to bring to any consultation—who will evaluate the hair loss, who will perform each part of the surgery, what their licensure and training are, and whether everyone involved is covered by malpractice insurance—are designed to surface these risks before money changes hands. A quote that seems inexpensive may reflect corners cut in training, supervision or planning, and the cost of undoing that damage, if it can be undone at all, typically exceeds the cost of doing it correctly the first time.

How Springs quotes: one all-in price after the Follicular Health Assessment

Springs Rejuvenation does not publish per-graft pricing or price tiers on the website because every restoration plan depends on the individual's degree of miniaturization, donor characteristics, hair caliber, curl pattern and long-term expectations. Instead, the practice offers a Follicular Health Assessment—a consultation during which Dr. Charles Pereyra evaluates the scalp under magnification, discusses medical history, reviews any medications being taken for hair preservation, and outlines a surgical and adjunctive plan tailored to the patient.

Following that assessment, the practice provides a single all-in price that includes the projected number of grafts, the harvesting method (shaved Micrograft FUE or No-Shave Micrograft FUE), physician time for both extraction and placement, facility and anesthesia, the Follicular Health Assessment itself, an initial recovery check and ongoing growth support. Financing options exist and are discussed at the consultation; the practice does not advertise terms or monthly payments in advance because those depend on the final quote and the patient's credit profile.

Because Dr. Pereyra performs the Micrograft FUE procedure himself—extraction and placement are not delegated to a physician assistant or technician—the quote reflects that level of direct physician involvement. For patients traveling from out of state, Springs offers a travel program: a virtual consultation to establish the plan, written pre-operative instructions, the procedure day, an in-person recovery check before the patient flies home, and remote follow-up thereafter.

Lowering lifetime cost: medication, timing and staged planning

The American Hair Loss Association's long-term planning page emphasizes that hair transplantation is not a one-time solution to progressive hair loss; the native hair that remains will continue to miniaturize unless supported by medical therapy. Patients who start or continue finasteride, minoxidil or other medications recommended by their physician can preserve the non-transplanted hair, which in turn reduces the number of grafts they will need over a lifetime. From a cost perspective, this means that the combination of a well-planned surgical session and consistent medical therapy may be less expensive over ten or twenty years than multiple surgical sessions without medication.

Timing also matters. A patient who undergoes a large session in their early twenties, before the full extent of their hair loss pattern is evident, may find that continued thinning behind the transplanted hairline creates an unnatural island of density. Waiting until the pattern is more stable—often the late twenties or early thirties—allows the surgeon to design a hairline and density plan that will age naturally, reducing the likelihood of needing revision or additional sessions to fill in new areas of loss.

Staged planning—dividing a large restoration into two or more sessions spaced a year or more apart—can also lower risk and long-term cost. The first session establishes the hairline and adds density to the most visible area; the physician and patient then observe how the grafts grow, how the native hair responds and whether the loss pattern progresses. If a second session is needed, it can be tailored to the updated picture, and if the native hair has stabilized on medication, fewer grafts may be required than originally projected. This approach requires patience but often results in a more natural appearance and better use of the donor reserve.

Frequently asked questions

Does insurance cover hair transplant procedures?

Hair restoration surgery is generally considered an elective cosmetic procedure and is not covered by health insurance plans in the United States. Some exceptions exist when hair loss results from trauma, burns or certain medical conditions, but coverage in those cases depends on the individual policy and requires documentation from the patient's physician. Patients interested in financing typically discuss payment plans and third-party medical lending options at the consultation, after the all-in price has been quoted. Springs Rejuvenation addresses financing on a case-by-case basis once the scope of the procedure is clear.

Why do quotes differ so much between clinics?

Variation in quoted prices reflects differences in who performs the surgery, the facility overhead, the harvesting method, follow-up commitments and regional cost of living. The International Society of Hair Restoration Surgery notes that prices vary regionally and not necessarily with the quality of care, and advises patients to ask who will perform each part of the procedure, what their licensure and training are, and whether anyone not licensed by the state will make incisions or harvest grafts. A lower quote may indicate that less experienced staff are performing the work, that follow-up is billed separately or that the clinic operates in a lower-cost market. A higher quote may reflect direct physician involvement, a no-shave technique or comprehensive post-operative support included in the price.

Is No-Shave FUE priced differently, and why?

No-Shave FUE—extracting follicular units without clipping the donor area—requires significantly longer time per graft because the physician must navigate through longer hair to identify and extract each unit without damaging surrounding follicles. The technique also demands a high level of skill to avoid transection and to harvest grafts in a scattered pattern that leaves no visible thinning. As a result, No-Shave FUE typically commands a higher fee than shaved FUE. Patients who cannot take time off work or who prefer to avoid the weeks-long wait for donor-area hair to grow back often find the premium worthwhile, but the choice should be discussed during the assessment.

Does adding an exosome protocol change the quote?

Exosome scalp protocols—investigational adjuncts in which concentrated extracellular vesicles are applied to the recipient and donor areas—add material cost, processing time and physician administration, which increases the overall quote. Stem cell and exosome therapies are not FDA approved to treat any disease, and the evidence for their role in hair restoration is early and mixed. Some published series suggest that exosomes may support graft survival or improve the quality of the scalp environment, but individual responses vary. During the Follicular Health Assessment, the physician reviews the available data, discusses whether the patient is a candidate for an exosome protocol and provides a revised quote if the patient elects to include it.

What should a quote itemize?

A complete quote should specify the projected number of grafts, the harvesting method, who will perform the extraction and placement, what the facility and anesthesia arrangements are, which follow-up visits and support services are included, and whether any regenerative adjuncts such as platelet-rich plasma or exosome protocols are part of the plan. The quote should also clarify what happens if the growth does not meet expectations—whether the practice offers additional grafts at no charge, discounted touch-up sessions or simply diagnostic follow-up. Patients should ask whether financing is available and on what terms, and whether the quoted price is fixed or subject to change if the graft count increases on the day of surgery.

About the author: Dr. Charles Pereyra, MD, is a board-certified emergency physician (NewYork-Presbyterian Brooklyn Methodist), a member of the International Society of Hair Restoration Surgery (ISHRS), and the physician who personally performs Micrograft FUE procedures at Springs Rejuvenation Hair.

Medical disclaimer: Stem cell and exosome therapy is not an FDA approved therapy and is considered to be in the experimental stages; it is not FDA approved to treat any disease. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Reviewed for medical accuracy by Dr. Charles Pereyra, MD, Medical Director, Springs Rejuvenation.